"Int J Technol Assess Health Care"[ Journal] - Search Results

Year	Number of Results
1985	36
1986	40
1987	53
1988	48
1989	54
1990	58
1991	103
1992	99
1993	58
1994	73
1995	78
1996	70
1997	57
1998	82
1999	74
2000	101
2001	61
2002	64
2003	70
2004	72
2005	72
2006	69
2007	68
2008	66
2009	132
2010	72
2011	62
2012	77
2013	64
2014	86
2015	66
2016	55
2017	103
2018	73
2019	79
2020	105
2021	71
2022	72
2023	80
2024	22

1

DEVELOPMENT OF A DISEASE-SPECIFIC HEALTH UTILITY SCORE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE FROM A DISCRETE CHOICE EXPERIMENT PATIENT PREFERENCE STUDY.

Jones B, Ryan M, Cook NS, Gutzwiller FS. Jones B, et al. Int J Technol Assess Health Care. 2024 May 2:1-31. doi: 10.1017/S0266462324000242. Online ahead of print. Int J Technol Assess Health Care. 2024. PMID: 38695141 No abstract available.

2

A SITUATIONAL AND STAKEHOLDER ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENT IN ZIMBABWE.

Dzingirai B, Dambiko P, Matyanga C, Manyau P, Tagwireyi D, Postma MJ, Mafirakureva N, van Hulst M. Dzingirai B, et al. Int J Technol Assess Health Care. 2024 Apr 29:1-26. doi: 10.1017/S0266462324000266. Online ahead of print. Int J Technol Assess Health Care. 2024. PMID: 38679461 No abstract available.

3

ASSESSING MEDICAL DEVICES: A QUALITATIVE STUDY FROM THE VALIDATE PERSPECTIVE.

Bloemen B, Oortwijn W. Bloemen B, et al. Int J Technol Assess Health Care. 2024 Apr 24:1-26. doi: 10.1017/S0266462324000254. Online ahead of print. Int J Technol Assess Health Care. 2024. PMID: 38654522 No abstract available.

4

Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders' perspectives.

Bayani DB, Wee HL. Bayani DB, et al. Int J Technol Assess Health Care. 2024 Apr 17;40(1):e22. doi: 10.1017/S0266462324000217. Int J Technol Assess Health Care. 2024. PMID: 38629196

5

Application of natural language processing to predict final recommendation of Brazilian health technology assessment reports.

Cardoso MMA, Machado-Rugolo J, Thabane L, da Rocha NC, Barbosa AMP, Komoda DS, de Almeida JTC, Curado DDSP, Weber SAT, de Andrade LGM. Cardoso MMA, et al. Int J Technol Assess Health Care. 2024 Apr 12;40(1):e19. doi: 10.1017/S0266462324000163. Int J Technol Assess Health Care. 2024. PMID: 38605654

6

Health Technology Assessment in Traditional and Complementary Medicine: a Scoping Review of International Activity and Examples of Acupuncture.

Ai DD, Sui BY, Duan CA, Xu Q, Zhao K. Ai DD, et al. Int J Technol Assess Health Care. 2024 Apr 5:1-37. doi: 10.1017/S0266462324000151. Online ahead of print. Int J Technol Assess Health Care. 2024. PMID: 38577775 No abstract available.

7

Design of a multiple criteria decision analysis framework for prioritizing high-impact health technologies in a regional health service.

Sánchez-Martínez FI, Abellán-Perpiñán JM, Martínez-Pérez JE, Gómez-Torres JL. Sánchez-Martínez FI, et al. Int J Technol Assess Health Care. 2024 Apr 5;40(1):e21. doi: 10.1017/S0266462324000205. Int J Technol Assess Health Care. 2024. PMID: 38576122

8

A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model.

Galekop MMJ, Del Bas JM, Calder PC, Uyl-De Groot CA, Redekop WK. Galekop MMJ, et al. Int J Technol Assess Health Care. 2024 Mar 6;40(1):e15. doi: 10.1017/S0266462324000060. Int J Technol Assess Health Care. 2024. PMID: 38444327

9

The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer.

Teppala S, Scuffham PA, Tuffaha H. Teppala S, et al. Int J Technol Assess Health Care. 2024 Mar 5;40(1):e14. doi: 10.1017/S0266462324000011. Int J Technol Assess Health Care. 2024. PMID: 38439629

10

HTA community perspectives on the use of patient preference information: lessons learned from a survey with members of HTA bodies.

Hiligsmann M, Liden B, Beaudart C, Germeni E, Hanna A, Joshi M, Koola CP, Stein B, Tonkinson M, Marshall D, Fifer S. Hiligsmann M, et al. Int J Technol Assess Health Care. 2024 Mar 5;40(1):e17. doi: 10.1017/S0266462324000138. Int J Technol Assess Health Care. 2024. PMID: 38439624 Review.

11

A blueprint for health technology assessment capacity building: lessons learned from Malta.

Abraham K, Kvamme I, Magrin Sammut S, de Vries S, Formosa T, Dupree R, Corro Ramos I, Goettsch W, Franken M. Abraham K, et al. Int J Technol Assess Health Care. 2024 Feb 29;40(1):e11. doi: 10.1017/S0266462324000072. Int J Technol Assess Health Care. 2024. PMID: 38419098

12

Preparing future doctors for evidence-based practice: a study on health technology assessment awareness and its predictors in Malaysia.

Mohamad NF, Mansor Z, Mahmud A, Mohamed Ghazali IM, Sarimin R. Mohamad NF, et al. Int J Technol Assess Health Care. 2024 Feb 28;40(1):e18. doi: 10.1017/S0266462324000102. Int J Technol Assess Health Care. 2024. PMID: 38415300

13

Conducting a health technology assessment in the West Bank, occupied Palestinian territory: lessons from a feasibility project.

Isbeih M, Heupink LF, Qaddomi S, Salman R, Chola L. Isbeih M, et al. Int J Technol Assess Health Care. 2024 Feb 15;40(1):e12. doi: 10.1017/S0266462324000084. Int J Technol Assess Health Care. 2024. PMID: 38357734 Review.

14

Evaluating clinical decision support software (CDSS): challenges for robust evidence generation.

Laka M, Carter D, Merlin T. Laka M, et al. Int J Technol Assess Health Care. 2024 Feb 8;40(1):e16. doi: 10.1017/S0266462324000059. Int J Technol Assess Health Care. 2024. PMID: 38328905

15

Introduction of hospital-based health technology assessment in China: experiences from seven pilot hospitals.

Lyu L, Shi W, Kidholm K, Bai F, Lin X, Fu J, Li T, Li G, Luo L, Wang T, Yang H. Lyu L, et al. Int J Technol Assess Health Care. 2024 Jan 29;40(1):e20. doi: 10.1017/S0266462323002738. Int J Technol Assess Health Care. 2024. PMID: 38282237

16

Early technology review: towards an expedited pathway.

Levin L, Sheldon M, McDonough RS, Aronson N, Rovers M, Gibson CM, Tunis SR, Kuntz RE. Levin L, et al. Int J Technol Assess Health Care. 2024 Jan 29;40(1):e13. doi: 10.1017/S0266462324000047. Int J Technol Assess Health Care. 2024. PMID: 38282208 Review.

17

Acceptability of self-administered antigen test for COVID-19 in the Philippines.

Yang JEU, Jackarain FH, de Vergara TIM, Santillan JF, Reyes PWC, Arellano MCVB, Garcia JTU, Samonte SJG, Marfori AJG, Guerrero AMS. Yang JEU, et al. Int J Technol Assess Health Care. 2024 Jan 17;40(1):e10. doi: 10.1017/S0266462324000035. Int J Technol Assess Health Care. 2024. PMID: 38230431

18

Response to heterogeneity of tests and platforms in economic evaluations: synthetic model adoption; derivatives of transferable practice.

Jones B. Jones B. Int J Technol Assess Health Care. 2024 Jan 15;40(1):e7. doi: 10.1017/S0266462323002787. Int J Technol Assess Health Care. 2024. PMID: 38221902 Free PMC article. No abstract available.

19

Quantifying stakeholders' preference for implantable medical devices in China: a discrete choice experiment.

Wan B, Shen J, Chen J, Weng L, Zhao P, Deng Y, Zhang L, Zhang F, Wang Y, Li X, Chang F, Ding H, Lu Y. Wan B, et al. Int J Technol Assess Health Care. 2024 Jan 15;40(1):e8. doi: 10.1017/S0266462323002799. Int J Technol Assess Health Care. 2024. PMID: 38221900 Free PMC article.

20

The National Health Service urgent cancer referral pathway for suspected urological cancers: early economic evaluation of a risk prediction test.

Cocco P, Smith AF, Neal RD, Shinkins B. Cocco P, et al. Int J Technol Assess Health Care. 2024 Jan 12;40(1):e9. doi: 10.1017/S0266462324000023. Int J Technol Assess Health Care. 2024. PMID: 38213290 Free PMC article.

21

Lifecycle evaluation of medical devices: supporting or jeopardizing patient outcomes? A comparative analysis of evaluation models.

Harkin KR, Sorensen J, Thomas S. Harkin KR, et al. Int J Technol Assess Health Care. 2024 Jan 5;40(1):e2. doi: 10.1017/S026646232300274X. Int J Technol Assess Health Care. 2024. PMID: 38179661 Free PMC article.

22

Using automated text classification to explore uncertainty in NICE appraisals for drugs for rare diseases.

Wiedmann L, Blumenau J, Carroll O, Cairns J. Wiedmann L, et al. Int J Technol Assess Health Care. 2024 Jan 5;40(1):e5. doi: 10.1017/S0266462323002805. Int J Technol Assess Health Care. 2024. PMID: 38178720 Free PMC article.

23

The value and impact of health technology assessment: discussions and recommendations from the 2023 Health Technology Assessment International Global Policy Forum.

Trowman R, Migliore A, Ollendorf DA. Trowman R, et al. Int J Technol Assess Health Care. 2023 Dec 22;39(1):e75. doi: 10.1017/S0266462323002763. Int J Technol Assess Health Care. 2023. PMID: 38130164

24

Advancing hospital-based health technology assessment: evaluating genomic panel contracting strategies for blood tumors through a multimethodology.

Afonso S, Vieira ACL, Pereira C, Oliveira MD. Afonso S, et al. Int J Technol Assess Health Care. 2023 Dec 22;39(1):e76. doi: 10.1017/S0266462323002751. Int J Technol Assess Health Care. 2023. PMID: 38130159

25

The extent and quality of qualitative evidence included in health technology assessments: a review of submissions to NICE and CADTH.

Szabo SM, Hawkins NS, Germeni E. Szabo SM, et al. Int J Technol Assess Health Care. 2023 Dec 21;40(1):e6. doi: 10.1017/S0266462323002829. Int J Technol Assess Health Care. 2023. PMID: 38126273 Free PMC article. Review.

26

A framework for local-level economic evaluation to inform implementation decisions: health service interventions to prevent hospital-acquired hypoglycemia.

Gray J, Thynne TR, Eaton V, Reade B, Larcombe R, Baldacchino L, Gehlert J, Hakendorf P, Karnon J; Southern Adelaide Local Health Network’s (SALHN) Hypoglycaemia Clinical Working Group. Gray J, et al. Int J Technol Assess Health Care. 2023 Dec 20;39(1):e74. doi: 10.1017/S0266462323002775. Int J Technol Assess Health Care. 2023. PMID: 38116650

27

Real-world evidence: experiences and challenges for decision making in Latin America.

García Martí S, Pichón-Riviere A, Augustovski F, Espinoza M. García Martí S, et al. Int J Technol Assess Health Care. 2023 Dec 18;39(1):e73. doi: 10.1017/S0266462323002647. Int J Technol Assess Health Care. 2023. PMID: 38108157

28

Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply.

Hogervorst MA, Vreman R, Heikkinen I, Oortwijn W. Hogervorst MA, et al. Int J Technol Assess Health Care. 2023 Dec 18;40(1):e1. doi: 10.1017/S0266462323002817. Int J Technol Assess Health Care. 2023. PMID: 38108142 Free PMC article. No abstract available.

29

Telemedicine and the assessment of clinician time: a scoping review.

Kidholm K, Jensen LK, Johansson M, Montori VM. Kidholm K, et al. Int J Technol Assess Health Care. 2023 Dec 15;40(1):e3. doi: 10.1017/S0266462323002830. Int J Technol Assess Health Care. 2023. PMID: 38099431 Free PMC article. Review.

30

The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshop.

Leahy TP, Durand-Zaleski I, Sampietro-Colom L, Kent S, Zöllner Y, Coyle D, Casadei G. Leahy TP, et al. Int J Technol Assess Health Care. 2023 Nov 20;39(1):e68. doi: 10.1017/S0266462323002702. Int J Technol Assess Health Care. 2023. PMID: 37981828

31

Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation.

Brönneke JB, Herr A, Reif S, Stern AD. Brönneke JB, et al. Int J Technol Assess Health Care. 2023 Nov 17;39(1):e72. doi: 10.1017/S0266462323002726. Int J Technol Assess Health Care. 2023. PMID: 37973549

32

Can knowledgeable experts assess costs and outcomes as if they were ignorant? An experiment within precision medicine evaluation.

Dulsamphan T, Juntama P, Suwanpanich C, Isaranuwatchai W, Silzle M, Poonmaksatit S, Boonsimma P, Shotelersuk V, Visudtibhan A, Lusawat A, Kamolvisit W, Kapol N, Lochid-Amnuay S, Sribundit N, Samprasit N, Morton A, Teerawattananon Y. Dulsamphan T, et al. Int J Technol Assess Health Care. 2023 Nov 17;40(1):e4. doi: 10.1017/S0266462323002714. Int J Technol Assess Health Care. 2023. PMID: 37973547 Free PMC article.

33

Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India.

Mathan Kumar S, Essakky S, Rajasulochana SR, Kar SS, Sivanatham P, Anandraj J, Parameswaran S, Soman B, Rajsekhar K, Stanley A. Mathan Kumar S, et al. Int J Technol Assess Health Care. 2023 Nov 14;39(1):e66. doi: 10.1017/S0266462323002623. Int J Technol Assess Health Care. 2023. PMID: 37960938

34

Mapping horizon scanning systems for medical devices: similarities, differences, and lessons learned.

Ormstad SS, Wild C, Erdös J, Moulton K. Ormstad SS, et al. Int J Technol Assess Health Care. 2023 Nov 7;39(1):e69. doi: 10.1017/S0266462323002684. Int J Technol Assess Health Care. 2023. PMID: 37933611 Review.

35

Priority setting for health technology adoption at the national level: Lessons learned over 25 years' experience.

Luxenburg O, Morginstin T, Myers V, Saban M, Shemer J, Wilf-Miron R. Luxenburg O, et al. Int J Technol Assess Health Care. 2023 Nov 6;39(1):e71. doi: 10.1017/S0266462323002611. Int J Technol Assess Health Care. 2023. PMID: 37929308

36

Moving from intervention management to disease management: a qualitative study exploring a systems approach to health technology assessment in Canada.

Richardson M, Sander B, Daneman N, Mighton C, Miller FA. Richardson M, et al. Int J Technol Assess Health Care. 2023 Nov 6;39(1):e67. doi: 10.1017/S0266462323002696. Int J Technol Assess Health Care. 2023. PMID: 37929295

37

Health technology assessment (HTA) readiness in Uganda: stakeholder's perceptions on the potential application of HTA to support national universal health coverage efforts.

Mayora C, Kazibwe J, Ssempala R, Nakimuli B, Ssennyonjo A, Ekirapa E, Byakika S, Aliti T, Musila T, Gad M, Vassall A, Ruiz F, Ssengooba F. Mayora C, et al. Int J Technol Assess Health Care. 2023 Oct 31;39(1):e65. doi: 10.1017/S0266462323002635. Int J Technol Assess Health Care. 2023. PMID: 37905441

38

Ethical and legal considerations in social media research for health technology assessment: conclusions from a scoping review.

Holtorf AP, Danyliv A, Krause A, Hanna A, Venable Y, Mattingly TJ 2nd, Huang LY, Pierre M, Silveira Silva A, Walsh D. Holtorf AP, et al. Int J Technol Assess Health Care. 2023 Oct 16;39(1):e62. doi: 10.1017/S0266462323000399. Int J Technol Assess Health Care. 2023. PMID: 37842838 Review.

39

Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP".

Grimm SE, Pouwels XGLV, Ramaekers BLT, Wijnen B, Grutters J, Joore MA. Grimm SE, et al. Int J Technol Assess Health Care. 2023 Oct 12;39(1):e70. doi: 10.1017/S026646232300260X. Int J Technol Assess Health Care. 2023. PMID: 37822085 No abstract available.

40

Proposing a health-specific organizational impact framework to evaluate organizational impacts in health technology assessments.

Mathy C, Pascal C, Bongiovanni-Delarozière I, Favez L. Mathy C, et al. Int J Technol Assess Health Care. 2023 Oct 11;39(1):e60. doi: 10.1017/S0266462323000508. Int J Technol Assess Health Care. 2023. PMID: 37818664

41

Economic evaluation of remote patient monitoring and organizational analysis according to patient involvement: a scoping review.

Le Goff-Pronost M, Bongiovanni-Delarozière I. Le Goff-Pronost M, et al. Int J Technol Assess Health Care. 2023 Sep 26;39(1):e59. doi: 10.1017/S0266462323002581. Int J Technol Assess Health Care. 2023. PMID: 37750813 Review.

42

Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France.

Martin T, Guercio A, Besseau H, Huot L, Guerre P, Atfeh J, Piazza L, Pineau J, Sabatier B, Borget I, Martelli N. Martin T, et al. Int J Technol Assess Health Care. 2023 Sep 21;39(1):e58. doi: 10.1017/S0266462323000521. Int J Technol Assess Health Care. 2023. PMID: 37732461

43

Using social media research in health technology assessment: stakeholder perspectives and scoping review.

Holtorf AP, Danyliv A, Huang LY, Venable Y, Hanna A, Krause A, Pierre M, Walsh D, Silveira Silva A, Lee SH, Mattingly TJ 2nd. Holtorf AP, et al. Int J Technol Assess Health Care. 2023 Sep 21;39(1):e63. doi: 10.1017/S0266462323002593. Int J Technol Assess Health Care. 2023. PMID: 37732455

44

International overview of health technology assessment training tools and materials for patients and consumers.

Low E, André-Vert J, Fanelli G, Galbraith M. Low E, et al. Int J Technol Assess Health Care. 2023 Sep 21;39(1):e61. doi: 10.1017/S0266462323000533. Int J Technol Assess Health Care. 2023. PMID: 37732420 Review.

45

Closing the loop between horizon scanning and health technology assessment - an overview of topics submitted for appraisal in England.

Khan SK, Gonzalez-Moral SG, Lanyi K, Ogunbayo D, Craig D. Khan SK, et al. Int J Technol Assess Health Care. 2023 Sep 11;39(1):e64. doi: 10.1017/S0266462323000491. Int J Technol Assess Health Care. 2023. PMID: 37690810

46

Emerging healthcare interventions: Patient-Centered Outcomes Research Institute's programmatic initiative - CORRIGENDUM.

Raman G, Vijaysimha M, Kopleff E, Dunham K, Martin G, Slutsky J, Lawrence W. Raman G, et al. Int J Technol Assess Health Care. 2023 Sep 7;39(1):e57. doi: 10.1017/S026646232300051X. Int J Technol Assess Health Care. 2023. PMID: 37675760 No abstract available.

47

Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults.

Xiang Y, Gan L, Du H, Hao Q, Aertgeerts B, Li S, Hu M. Xiang Y, et al. Int J Technol Assess Health Care. 2023 Aug 31;39(1):e53. doi: 10.1017/S0266462323000296. Int J Technol Assess Health Care. 2023. PMID: 37650314

48

HTA capacity building in Asia: towards one goal.

Mundy L, Maddern G. Mundy L, et al. Int J Technol Assess Health Care. 2023 Aug 15;39(1):e56. doi: 10.1017/S0266462323000405. Int J Technol Assess Health Care. 2023. PMID: 37581298

49

Do France, Germany, and Italy agree on the added therapeutic value of medicines?

Casilli G, Lidonnici D, Jommi C, De Nigris M, Genazzani AA. Casilli G, et al. Int J Technol Assess Health Care. 2023 Aug 15;39(1):e54. doi: 10.1017/S026646232300048X. Int J Technol Assess Health Care. 2023. PMID: 37580971 Free article.

50

Patient and citizen participation at the organizational level in health technology assessment: an exploratory study in five jurisdictions.

Nabarette H, Chastenay MH, Dupont JK, Ganache I, Single ANV. Nabarette H, et al. Int J Technol Assess Health Care. 2023 Aug 8;39(1):e51. doi: 10.1017/S0266462323000417. Int J Technol Assess Health Care. 2023. PMID: 37551103 Review.

51

A systematic review of the accessibility, acceptability, safety, efficiency, clinical effectiveness, and cost-effectiveness of private cataract and orthopedic surgery clinics.

Akpinar I, Kirwin E, Tjosvold L, Chojecki D, Round J. Akpinar I, et al. Int J Technol Assess Health Care. 2023 Aug 1;39(1):e47. doi: 10.1017/S0266462323000120. Int J Technol Assess Health Care. 2023. PMID: 37525477

52

A first exploration of the economic consequences of an autonomous surgical robot for lateral skull base surgery: an early health technology assessment.

Nabuurs CH, Kievit W, Haegens L, Grutters JPC, Kunst HPM. Nabuurs CH, et al. Int J Technol Assess Health Care. 2023 Jul 31;39(1):e46. doi: 10.1017/S0266462323000430. Int J Technol Assess Health Care. 2023. PMID: 37522518

53

An evaluation of managed access agreements in England based on stakeholder experience.

Farmer C, Barnish MS, Trigg LA, Hayward S, Shaw N, Crathorne L, Strong T, Groves B, Spoors J, Melendez Torres GJ. Farmer C, et al. Int J Technol Assess Health Care. 2023 Jul 27;39(1):e55. doi: 10.1017/S0266462323000478. Int J Technol Assess Health Care. 2023. PMID: 37497570

54

National health technology assessment in Turkiye after a decade: are key principles followed?

Avşar TS, Yıldırım HH. Avşar TS, et al. Int J Technol Assess Health Care. 2023 Jul 24;39(1):e52. doi: 10.1017/S0266462323000466. Int J Technol Assess Health Care. 2023. PMID: 37485616

55

Institutionalizing health technology assessment in Ethiopia: seizing the window of opportunity.

Erku D, Walker D, Caruso AA, Wubishet B, Assefa Y, Abera S, Hailu A, Scuffham P. Erku D, et al. Int J Technol Assess Health Care. 2023 Jul 21;39(1):e49. doi: 10.1017/S0266462323000454. Int J Technol Assess Health Care. 2023. PMID: 37477002 Review.

56

Effectiveness and safety of caplacizumab in acquired thrombotic thrombocytopenic purpura: health technology assessment and classification according to the methodology established in Colombia.

Soto-Mora JA, Gómez-Espitia LM, Lasalvia P, Castellanos Moreno CA, Casallas Vanegas CA, Londoño Gutiérrez SA. Soto-Mora JA, et al. Int J Technol Assess Health Care. 2023 Jul 21;39(1):e48. doi: 10.1017/S0266462323000442. Int J Technol Assess Health Care. 2023. PMID: 37476982

57

Ethics information retrieval in HTA: state of current practice.

Horton J, DeJean D, Farrah K, Hodgson A, Kaunelis D, Walter M. Horton J, et al. Int J Technol Assess Health Care. 2023 Jul 19;39(1):e43. doi: 10.1017/S0266462323000247. Int J Technol Assess Health Care. 2023. PMID: 37465961

58

Appropriateness of strategy comparisons in cost-effectiveness analyses of infant pneumococcal vaccination: a systematic review.

Scheffer MMJ, Coffeng LE, O'Mahony JF. Scheffer MMJ, et al. Int J Technol Assess Health Care. 2023 Jul 12;39(1):e42. doi: 10.1017/S0266462323000351. Int J Technol Assess Health Care. 2023. PMID: 37435736

59

Early access schemes for innovative health technologies: the views of international stakeholders.

Farmer C, O'Toole B, Barnish MS, Trigg LA, Hayward S, Crathorne L, Kasten Z, Spoors J, Melendez-Torres GJ. Farmer C, et al. Int J Technol Assess Health Care. 2023 Jul 6;39(1):e45. doi: 10.1017/S0266462323000429. Int J Technol Assess Health Care. 2023. PMID: 37409515

60

Deliberative processes in health technology assessment of medicines: the case of Spain.

Pinilla-Dominguez P, Pinilla-Dominguez J. Pinilla-Dominguez P, et al. Int J Technol Assess Health Care. 2023 Jul 5;39(1):e50. doi: 10.1017/S0266462323000387. Int J Technol Assess Health Care. 2023. PMID: 37403252 Review.

61

Emerging healthcare interventions: Patient-Centered Outcomes Research Institute's programmatic initiative.

Raman G, Vijaysimha M, Kopleff E, Dunham K, Martin G, Slutsky J, Lawrence W. Raman G, et al. Int J Technol Assess Health Care. 2023 Jun 20;39(1):e36. doi: 10.1017/S0266462323000284. Int J Technol Assess Health Care. 2023. PMID: 37336780 Review.

62

Healthcare priority-setting criteria and social values in Iran: an investigation of local evidence.

Goudarzi Z, Bijlmakers L, Nouhi M, Jahangiri R, Heydari M, Simangolwa W, Hakimzadeh SM, Jara KT. Goudarzi Z, et al. Int J Technol Assess Health Care. 2023 Jun 19;39(1):e37. doi: 10.1017/S0266462323000302. Int J Technol Assess Health Care. 2023. PMID: 37334802 Review.

63

Decision making for early surgical technology adoption into Canada's healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities.

Shoman H, Tanzer M. Shoman H, et al. Int J Technol Assess Health Care. 2023 Jun 19;39(1):e41. doi: 10.1017/S0266462323000363. Int J Technol Assess Health Care. 2023. PMID: 37334665 Review.

64

Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group.

Hogervorst MA, Vreman R, Heikkinen I, Bagchi I, Gutierrez-Ibarluzea I, Ryll B, Eichler HG, Petelos E, Tunis S, Sapede C, Goettsch W, Janssens R, Huys I, Barbier L, DeJean D, Strammiello V, Lingri D, Goodall M, Papadaki M, Toussi M, Voulgaraki D, Mitan A, Oortwijn W. Hogervorst MA, et al. Int J Technol Assess Health Care. 2023 Jun 16;39(1):e40. doi: 10.1017/S0266462323000375. Int J Technol Assess Health Care. 2023. PMID: 37325997 Review.

65

Clinical effectiveness of fluticasone furoate nasal spray for perennial allergic rhinitis in children: a comprehensive review.

Rivera PA. Rivera PA. Int J Technol Assess Health Care. 2023 Jun 16;39(1):e35. doi: 10.1017/S026646232300034X. Int J Technol Assess Health Care. 2023. PMID: 37325979 Review.

66

A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies.

Schnitzler L, Roberts TE, Jackson LJ, Paulus ATG, Evers SMAA. Schnitzler L, et al. Int J Technol Assess Health Care. 2023 Jun 16;39(1):e34. doi: 10.1017/S0266462323000193. Int J Technol Assess Health Care. 2023. PMID: 37325977

67

The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries' past health technology assessments.

Vreman RA, van Hoof D, Nachtnebel A, Daems J, van de Casteele M, Fogarty E, Adams R, Timmers L. Vreman RA, et al. Int J Technol Assess Health Care. 2023 Jun 15;39(1):e44. doi: 10.1017/S0266462323000338. Int J Technol Assess Health Care. 2023. PMID: 37317832

68

A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value.

Farris M, Goodall S, De Abreu Lourenco R. Farris M, et al. Int J Technol Assess Health Care. 2023 Jun 14;39(1):e38. doi: 10.1017/S0266462323000326. Int J Technol Assess Health Care. 2023. PMID: 37313789

69

Expert opinion on a consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies: qualitative interviews.

Schnitzler L, Paulus ATG, Evers SMAA, Roberts TE, Jackson LJ. Schnitzler L, et al. Int J Technol Assess Health Care. 2023 Jun 9;39(1):e33. doi: 10.1017/S0266462323000181. Int J Technol Assess Health Care. 2023. PMID: 37293924

70

Cost-effectiveness of neuromuscular electrical stimulation for the treatment of mild obstructive sleep apnea: an exploratory analysis.

Liu S, Cao KN, Garner AM, Punjabi NM, Pietzsch JB. Liu S, et al. Int J Technol Assess Health Care. 2023 Jun 6;39(1):e32. doi: 10.1017/S0266462323000272. Int J Technol Assess Health Care. 2023. PMID: 37277322

71

Best practice considerations on the assessment of robotic assisted surgical systems: results from an international consensus expert panel.

Erskine J, Abrishami P, Charter R, Cicchetti A, Culbertson R, Faria E, Hiatt JC, Khan J, Maddern G, Patel A, Rha KH, Shah P, Sooriakumaran P, Tackett S, Turchetti G, Chalkidou A. Erskine J, et al. Int J Technol Assess Health Care. 2023 Jun 5;39(1):e39. doi: 10.1017/S0266462323000314. Int J Technol Assess Health Care. 2023. PMID: 37272397 Review.

72

A review of HTA guidelines on societal and novel value elements.

Breslau RM, Cohen JT, Diaz J, Malcolm B, Neumann PJ. Breslau RM, et al. Int J Technol Assess Health Care. 2023 May 25;39(1):e31. doi: 10.1017/S026646232300017X. Int J Technol Assess Health Care. 2023. PMID: 37226807 Review.

73

Demonstrating proof of concept for value-based agreements in Europe: two real-world cases.

Griffiths EA, Odelade OE, Gostkorzewicz J, Cordero L. Griffiths EA, et al. Int J Technol Assess Health Care. 2023 May 22;39(1):e30. doi: 10.1017/S0266462323000260. Int J Technol Assess Health Care. 2023. PMID: 37212053

74

Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains.

Zimmermann G, Michelmore S, Hiligsmann M. Zimmermann G, et al. Int J Technol Assess Health Care. 2023 May 22;39(1):e29. doi: 10.1017/S0266462323000077. Int J Technol Assess Health Care. 2023. PMID: 37212049

75

Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia.

Gao Y, Laka M, Merlin T. Gao Y, et al. Int J Technol Assess Health Care. 2023 May 18;39(1):e28. doi: 10.1017/S0266462323000259. Int J Technol Assess Health Care. 2023. PMID: 37198927 Review.

76

A HTA of what? Reframing through including patient perspectives in health technology assessment processes.

Gunn CJ, Regeer BJ, Zuiderent-Jerak T. Gunn CJ, et al. Int J Technol Assess Health Care. 2023 May 18;39(1):e27. doi: 10.1017/S0266462323000132. Int J Technol Assess Health Care. 2023. PMID: 37198925

77

Expanding health technology assessment towards broader value: Ireland as a case study.

Kinchin I, Walshe V, Normand C, Coast J, Elliott R, Kroll T, Kinghorn P, Thompson A, Viney R, Currow D, O'Mahony JF. Kinchin I, et al. Int J Technol Assess Health Care. 2023 May 2;39(1):e26. doi: 10.1017/S0266462323000235. Int J Technol Assess Health Care. 2023. PMID: 37129030 Review.

78

Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review.

Zhang Y, Peña MT, Fletcher LM, Lal L, Swint JM, Reneker JC. Zhang Y, et al. Int J Technol Assess Health Care. 2023 Apr 28;39(1):e25. doi: 10.1017/S0266462323000156. Int J Technol Assess Health Care. 2023. PMID: 37114456

79

Involvement of information specialists and statisticians in systematic reviews.

Waffenschmidt S, Bender R. Waffenschmidt S, et al. Int J Technol Assess Health Care. 2023 Apr 25;39(1):e22. doi: 10.1017/S026646232300020X. Int J Technol Assess Health Care. 2023. PMID: 37096439 Review.

80

Beyond clinical and cost-effectiveness: The contribution of qualitative research to health technology assessment.

Germeni E, Szabo S. Germeni E, et al. Int J Technol Assess Health Care. 2023 Apr 24;39(1):e23. doi: 10.1017/S0266462323000211. Int J Technol Assess Health Care. 2023. PMID: 37092753

81

Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations.

Elvidge J, Summerfield A, Knies S, Németh B, Kaló Z, Goettsch W, Dawoud DM; COVID-19 HTA Best-Practice Development Group. Elvidge J, et al. Int J Technol Assess Health Care. 2023 Apr 24;39(1):e24. doi: 10.1017/S0266462323000223. Int J Technol Assess Health Care. 2023. PMID: 37092749

82

Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis.

Stamuli E, Corry S, Foss P. Stamuli E, et al. Int J Technol Assess Health Care. 2023 Apr 19;39(1):e21. doi: 10.1017/S0266462323000168. Int J Technol Assess Health Care. 2023. PMID: 37074007

83

Patient-based evidence: its role in decision making on end-of-life, orphan, and ultra-orphan medicines.

Hems S, Taylor L, Jones J, Holmes E. Hems S, et al. Int J Technol Assess Health Care. 2023 Apr 11;39(1):e19. doi: 10.1017/S026646232300003X. Int J Technol Assess Health Care. 2023. PMID: 37039484

84

Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.

Wang T, McAuslane N, Goettsch WG, Leufkens HGM, De Bruin ML. Wang T, et al. Int J Technol Assess Health Care. 2023 Apr 11;39(1):e20. doi: 10.1017/S0266462323000144. Int J Technol Assess Health Care. 2023. PMID: 37039100

85

Health technology assessment for oral health in the past decade: a scoping review.

Bhatia S, Mohanty V, Balappanavar AY, Chahar P, Rijhwani K, Gupta R. Bhatia S, et al. Int J Technol Assess Health Care. 2023 Mar 27;39(1):e18. doi: 10.1017/S0266462322003312. Int J Technol Assess Health Care. 2023. PMID: 36971267 Review.

86

Clinical effectiveness reporting of novel cancer drugs in the context of non-proportional hazards: a review of nice single technology appraisals.

Salmon D, Melendez-Torres GJ. Salmon D, et al. Int J Technol Assess Health Care. 2023 Mar 8;39(1):e16. doi: 10.1017/S0266462323000119. Int J Technol Assess Health Care. 2023. PMID: 36883316 Review.

87

The added value of applying a disinvestment approach to the process of health technology assessment in Italy.

Cadeddu C, Regazzi L, Di Brino E, Basile M, Cascini F, Paladini A, Rumi F, Cicchetti A, Ricciardi W. Cadeddu C, et al. Int J Technol Assess Health Care. 2023 Mar 2;39(1):e17. doi: 10.1017/S0266462323000107. Int J Technol Assess Health Care. 2023. PMID: 36861658

88

Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment.

Trowman R, Migliore A, Ollendorf DA. Trowman R, et al. Int J Technol Assess Health Care. 2023 Feb 23;39(1):e15. doi: 10.1017/S0266462323000090. Int J Technol Assess Health Care. 2023. PMID: 36815310

89

Environmental impact assessment in health technology assessment: principles, approaches, and challenges.

Toolan M, Walpole S, Shah K, Kenny J, Jónsson P, Crabb N, Greaves F. Toolan M, et al. Int J Technol Assess Health Care. 2023 Feb 23;39(1):e13. doi: 10.1017/S0266462323000041. Int J Technol Assess Health Care. 2023. PMID: 36815229 Free article.

90

Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations.

Ferrante di Ruffano L, Harris IM, Zhelev Z, Davenport C, Mallett S, Peters J, Takwoingi Y, Deeks J, Hyde C. Ferrante di Ruffano L, et al. Int J Technol Assess Health Care. 2023 Feb 21;39(1):e14. doi: 10.1017/S0266462323000065. Int J Technol Assess Health Care. 2023. PMID: 36803886 Free PMC article.

91

Stakeholder preferences for attributes of digital health technologies to consider in health service funding.

von Huben A, Howell M, Norris S, Wong KC, Tang J, Kazi S, Laranjo L, Chow CK, Howard K. von Huben A, et al. Int J Technol Assess Health Care. 2023 Feb 14;39(1):e12. doi: 10.1017/S0266462323000089. Int J Technol Assess Health Care. 2023. PMID: 36786028

92

A decision-support tool for funding health innovations at a tertiary academic medical center.

Cai Y, Nazeha N, Perera S, Thiery AH, Girard MJA, Lee CE, Hong W, Graves N. Cai Y, et al. Int J Technol Assess Health Care. 2023 Feb 13;39(1):e11. doi: 10.1017/S0266462323000028. Int J Technol Assess Health Care. 2023. PMID: 36779272 Review.

93

Novel approach to decision making for orphan drugs.

Decker B, Mlcoch T, Pustovalova A, Dolezal T. Decker B, et al. Int J Technol Assess Health Care. 2023 Feb 7;39(1):e10. doi: 10.1017/S0266462323000053. Int J Technol Assess Health Care. 2023. PMID: 36748356

94

Scaling up health technology assessment capacities in selected African countries - A conceivable route ahead.

Mueller D, Alouane L, Jameleddine M, Lenoir-Wijnkoop I. Mueller D, et al. Int J Technol Assess Health Care. 2023 Jan 30;39(1):e9. doi: 10.1017/S0266462323000016. Int J Technol Assess Health Care. 2023. PMID: 36710506

95

A technical review of the ISPOR Presentations Database: an update on changes to the database from the authors and ISPOR.

Cooper C, Brown A, Court R, Schauberger U, Pizzi L, Willke R. Cooper C, et al. Int J Technol Assess Health Care. 2023 Jan 24;39(1):e8. doi: 10.1017/S0266462322003324. Int J Technol Assess Health Care. 2023. PMID: 36691376 No abstract available.

96

The value of reducing arthroscopic partial meniscectomy in the treatment of degenerative meniscus tears: a budget impact analysis.

van Well EB, Wijn SRW, Hannink G, Grutters JPC, Rovers MM. van Well EB, et al. Int J Technol Assess Health Care. 2023 Jan 18;39(1):e7. doi: 10.1017/S0266462322003361. Int J Technol Assess Health Care. 2023. PMID: 36650723

97

A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK.

Tappenden P, Navega Biz A, Hernández Alava M, Sasso A, Sutton L, Ennis K, Elliott R, Wildman M. Tappenden P, et al. Int J Technol Assess Health Care. 2023 Jan 17;39(1):e6. doi: 10.1017/S0266462322003373. Int J Technol Assess Health Care. 2023. PMID: 36647697

98

Informing decision makers about public preferences for different modalities of cancer treatment in the Rhône-Alps region in France.

Margier J, Gafni A, Moumjid N. Margier J, et al. Int J Technol Assess Health Care. 2023 Jan 16;39(1):e5. doi: 10.1017/S0266462322000599. Int J Technol Assess Health Care. 2023. PMID: 36644918

99

Using early health economic modeling to inform medical innovation development: a soft robotic sock in poststroke patients in Singapore.

Wang Y, Low FZ, Low YY, Lai HS, Lim JH, Yeow CH, Teerawattananon Y. Wang Y, et al. Int J Technol Assess Health Care. 2023 Jan 11;39(1):e4. doi: 10.1017/S026646232200335X. Int J Technol Assess Health Care. 2023. PMID: 36628458

100

Genuine policy learning is fundamental: the journey of the United Arab Emirates toward the establishment of health technology assessment.

Ahmad M, Akhras KS, Saleh S. Ahmad M, et al. Int J Technol Assess Health Care. 2023 Jan 9;39(1):e3. doi: 10.1017/S0266462322003348. Int J Technol Assess Health Care. 2023. PMID: 36621844

101

Direct healthcare costs of non-metastatic castration-resistant prostate cancer in Italy.

Borsoi L, Ciani O, Fornarini G, Oderda M, Sciarra A, Vetrini D, Luccarini I. Borsoi L, et al. Int J Technol Assess Health Care. 2023 Jan 6;39(1):e2. doi: 10.1017/S0266462322003336. Int J Technol Assess Health Care. 2023. PMID: 36606465 Free article.

102

Patient-reported outcomes using a wearable cardioverter-defibrillator: results from a systematic review.

Aidelsburger P, Seyed-Ghaemi J, Bonderman D. Aidelsburger P, et al. Int J Technol Assess Health Care. 2023 Jan 6;39(1):e1. doi: 10.1017/S0266462322003300. Int J Technol Assess Health Care. 2023. PMID: 36606325

103

Deliberative processes in decision making informed by health technology assessment in Latin America.

Alcaraz A, Pichon-Riviere A, García-Martí S, Alfie V, Augustovski F, Castro H. Alcaraz A, et al. Int J Technol Assess Health Care. 2022 Dec 16;38(1):e86. doi: 10.1017/S0266462322003294. Int J Technol Assess Health Care. 2022. PMID: 36524558

104

Patient Perspectives: An Integral Part of Health Technology Assessment Methodology.

Spangler J, Huth T, Xie R. Spangler J, et al. Int J Technol Assess Health Care. 2022 Dec 16;38(1):e85. doi: 10.1017/S0266462322003270. Int J Technol Assess Health Care. 2022. PMID: 36524546 No abstract available.

105

Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis.

Armoiry X, Wang-Steverding X, Connock M, Grove A, Clarke A, Arun T, Counsell C, Auguste P. Armoiry X, et al. Int J Technol Assess Health Care. 2022 Dec 13;38(1):e83. doi: 10.1017/S0266462322003269. Int J Technol Assess Health Care. 2022. PMID: 36510406 Review.

106

Incorporating environmental and sustainability considerations into health technology assessment and clinical and public health guidelines: a scoping review.

Pinho-Gomes AC, Yoo SH, Allen A, Maiden H, Shah K, Toolan M. Pinho-Gomes AC, et al. Int J Technol Assess Health Care. 2022 Dec 13;38(1):e84. doi: 10.1017/S0266462322003282. Int J Technol Assess Health Care. 2022. PMID: 36510398 Review.

107

The role of ethical analysis in conducting a health technology assessment of medical treatments for gender dysphoria.

Saarni SI, Uusitalo S, Autti-Rämö I. Saarni SI, et al. Int J Technol Assess Health Care. 2022 Nov 14;38(1):e82. doi: 10.1017/S0266462322003257. Int J Technol Assess Health Care. 2022. PMID: 36373501

108

A model to assess the impact of digital technologies on the health-related quality of life.

Lockl J, Schick D, Stoetzer JC, Huff K. Lockl J, et al. Int J Technol Assess Health Care. 2022 Nov 11;38(1):e81. doi: 10.1017/S0266462322003245. Int J Technol Assess Health Care. 2022. PMID: 36367148 Free PMC article.

109

Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks.

Pascal C, Mathy C, Bongiovanni I, Konishi M. Pascal C, et al. Int J Technol Assess Health Care. 2022 Nov 2;38(1):e80. doi: 10.1017/S0266462322003221. Int J Technol Assess Health Care. 2022. PMID: 36321449

110

Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?

Capkun G, Corry S, Dowling O, Asad Zadeh Vosta Kolaei F, Takyar S, Furtado C, Jónsson P, Kleinermans D, Lambert L, Schiel A, Facey K. Capkun G, et al. Int J Technol Assess Health Care. 2022 Nov 2;38(1):e79. doi: 10.1017/S0266462322000605. Int J Technol Assess Health Care. 2022. PMID: 36321447

111

Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices.

Heupink LF, Peacocke EF, Sæterdal I, Chola L, Frønsdal K. Heupink LF, et al. Int J Technol Assess Health Care. 2022 Nov 2;38(1):e78. doi: 10.1017/S026646232200321X. Int J Technol Assess Health Care. 2022. PMID: 36321421 Review.

112

Using discrete-choice experiments to elicit preferences for digital wearable health technology for self-management of chronic kidney disease.

Gc VS, Iglesias CP, Erdem S, Hassan L, Peek N, Manca A. Gc VS, et al. Int J Technol Assess Health Care. 2022 Oct 26;38(1):e77. doi: 10.1017/S0266462322003233. Int J Technol Assess Health Care. 2022. PMID: 36286261 Review.

113

Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body.

Arntsen KA, Blount LG, Dickerson BJ, Koola CP, Venable Y, Wildman P. Arntsen KA, et al. Int J Technol Assess Health Care. 2022 Oct 20;38(1):e76. doi: 10.1017/S0266462322000587. Int J Technol Assess Health Care. 2022. PMID: 36263665

114

Neglected impacts of patient decision-making associated with genetic testing.

Milverton J, Carter D. Milverton J, et al. Int J Technol Assess Health Care. 2022 Oct 17;38(1):e75. doi: 10.1017/S0266462322000575. Int J Technol Assess Health Care. 2022. PMID: 36250399

115

Model for ASsessing the value of Artificial Intelligence in medical imaging (MAS-AI).

Fasterholdt I, Kjølhede T, Naghavi-Behzad M, Schmidt T, Rautalammi QTS, Hildebrandt MG, Gerdes A, Barkler A, Kidholm K, Rac VE, Rasmussen BSB. Fasterholdt I, et al. Int J Technol Assess Health Care. 2022 Oct 3;38(1):e74. doi: 10.1017/S0266462322000551. Int J Technol Assess Health Care. 2022. PMID: 36189821 Review.

116

Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis.

Rojas-Gómez AM, Serrano JJ, Rosselli D. Rojas-Gómez AM, et al. Int J Technol Assess Health Care. 2022 Sep 28;38(1):e73. doi: 10.1017/S0266462322000563. Int J Technol Assess Health Care. 2022. PMID: 36169019

117

Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature.

Nurchis MC, Riccardi MT, Damiani G. Nurchis MC, et al. Int J Technol Assess Health Care. 2022 Aug 26;38(1):e71. doi: 10.1017/S0266462322000496. Int J Technol Assess Health Care. 2022. PMID: 36016516

118

Implementation of a new Digi-HTA process for digital health technologies in Finland.

Haverinen J, Turpeinen M, Falkenbach P, Reponen J. Haverinen J, et al. Int J Technol Assess Health Care. 2022 Aug 19;38(1):e68. doi: 10.1017/S0266462322000502. Int J Technol Assess Health Care. 2022. PMID: 35983625

119

Economic evaluation of genomic/genetic tests: a review and future directions.

Bouttell J, Heggie R, Oien K, Romaniuk A, VanSteenhouse H, von Delft S, Hawkins N. Bouttell J, et al. Int J Technol Assess Health Care. 2022 Aug 1;38(1):e67. doi: 10.1017/S0266462322000484. Int J Technol Assess Health Care. 2022. PMID: 36317681 Review.

120

A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.

Zozaya N, Arrizubieta Basterrechea MI, Bollo E, Castellví I, Espín J, Ortego N, Poveda-Andrés JL, Rodríguez Portal JA, Rivero A, Marcos-Rodríguez JA, Verde L. Zozaya N, et al. Int J Technol Assess Health Care. 2022 Aug 1;38(1):e64. doi: 10.1017/S0266462322000459. Int J Technol Assess Health Care. 2022. PMID: 35912833 Free article.

121

Cost-utility of a web-based intervention to promote maternal mental health among postpartum women presenting low risk for postpartum depression.

Monteiro F, Antunes P, Pereira M, Canavarro MC, Fonseca A. Monteiro F, et al. Int J Technol Assess Health Care. 2022 Jul 21;38(1):e62. doi: 10.1017/S0266462322000447. Int J Technol Assess Health Care. 2022. PMID: 35861012 Clinical Trial.

122

Assessing progression of health technology assessment implementation in Asia: a balanced scorecard for cross comparison of selected countries in Asia.

Kumar R, Suharlim C, Amaris Caruso A, Gilmartin C, Mehra M, Castro HE. Kumar R, et al. Int J Technol Assess Health Care. 2022 Jul 21;38(1):e60. doi: 10.1017/S0266462322000423. Int J Technol Assess Health Care. 2022. PMID: 35858879

123

Disinvestment in healthcare: a scoping review of systematic reviews.

Kamaruzaman HF, Grieve E, Wu O. Kamaruzaman HF, et al. Int J Technol Assess Health Care. 2022 Jul 20;38(1):e69. doi: 10.1017/S0266462322000514. Int J Technol Assess Health Care. 2022. PMID: 35853843 Review.

124

Development, testing, and implementation of a new procedure to assess the clinical added benefit of pharmaceuticals.

Dóczy V, Wernerné Sódar B, Hölgyesi Á, Merész G, Gaál P. Dóczy V, et al. Int J Technol Assess Health Care. 2022 Jul 12;38(1):e58. doi: 10.1017/S0266462322000411. Int J Technol Assess Health Care. 2022. PMID: 35819299

125

Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis.

Carey N, Leahy J, Trela-Larsen L, McCullagh L, Barry M. Carey N, et al. Int J Technol Assess Health Care. 2022 Jul 11;38(1):e56. doi: 10.1017/S0266462322000356. Int J Technol Assess Health Care. 2022. PMID: 35815435

126

Economic feasibility of a novel tool to assist extubation decision-making: an early health economic modeling.

Zheng K, Kumar S, Sarti AJ, Herry CL, Seely AJE, Thavorn K. Zheng K, et al. Int J Technol Assess Health Care. 2022 Jul 11;38(1):e66. doi: 10.1017/S0266462322000472. Int J Technol Assess Health Care. 2022. PMID: 35811412

127

Test-retest reliability of the Cost for Patients Questionnaire.

Poder TG, Coulibaly LP, Hassan AI, Conombo B, Laberge M. Poder TG, et al. Int J Technol Assess Health Care. 2022 Jul 11;38(1):e65. doi: 10.1017/S0266462322000460. Int J Technol Assess Health Care. 2022. PMID: 35811410

128

Redefining Health Technology Assessment: A Comment on "The New Definition of Health Technology Assessment: A Milestone in International Collaboration".

Culyer A, Husereau D. Culyer A, et al. Int J Technol Assess Health Care. 2022 Jul 5;38(1):e54. doi: 10.1017/S0266462321001756. Int J Technol Assess Health Care. 2022. PMID: 35787312

129

Response to redefining health technology assessment: a comment on "the new definition of health technology assessment: a milestone in international collaboration".

O'Rourke B, Oortwijn W, Schuller T. O'Rourke B, et al. Int J Technol Assess Health Care. 2022 Jul 5;38(1):e55. doi: 10.1017/S0266462322000344. Int J Technol Assess Health Care. 2022. PMID: 35787309 No abstract available.

130

Adjustment of publication bias using a cumulative meta-analytic framework.

Canestaro WJ, Devine EB, Bansal A, Sullivan SD, Carlson JJ. Canestaro WJ, et al. Int J Technol Assess Health Care. 2022 Jun 28;38(1):e61. doi: 10.1017/S0266462322000435. Int J Technol Assess Health Care. 2022. PMID: 35761433

131

Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach.

van der Wilt GJ, Bloemen B, Grin J, Gutierrez-Ibarluzea I, Sampietro-Colom L, Refolo P, Sacchini D, Hofmann B, Sandman L, Oortwijn W. van der Wilt GJ, et al. Int J Technol Assess Health Care. 2022 Jun 23;38(1):e52. doi: 10.1017/S0266462321001768. Int J Technol Assess Health Care. 2022. PMID: 35959563

132

Health technology assessment: A matter of facts and values.

van der Wilt GJ, Oortwijn W; VALIDATE-HTA Consortium. van der Wilt GJ, et al. Int J Technol Assess Health Care. 2022 Jun 23;38(1):e53. doi: 10.1017/S0266462322000101. Int J Technol Assess Health Care. 2022. PMID: 35950525

133

Methods and criteria for the assessment of orphan drugs: a scoping review.

Mohammadshahi M, Olyaeemanesh A, Ehsani-Chimeh E, Mobinizadeh M, Fakoorfard Z, Akbari Sari A, Aghighi M. Mohammadshahi M, et al. Int J Technol Assess Health Care. 2022 Jun 22;38(1):e59. doi: 10.1017/S0266462322000393. Int J Technol Assess Health Care. 2022. PMID: 35730573 Review.

134

Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project.

Grin J, Bloemen B, Gutierrez-Ibarluzea I, Hofmann B, Oortwijn W, Refolo P, Sacchini D, Sampietro-Colom L, Sandman L, van der Wilt GJ. Grin J, et al. Int J Technol Assess Health Care. 2022 Jun 21;38(1):e63. doi: 10.1017/S0266462322000204. Int J Technol Assess Health Care. 2022. PMID: 35726526

135

Current Issues in Health Technology Assessment of Cancer Therapies: A Survey of Stakeholders and Opinion Leaders in Australia.

Kim H, Liew D, Goodall S. Kim H, et al. Int J Technol Assess Health Care. 2022 Jun 15;38(1):e49. doi: 10.1017/S0266462322000368. Int J Technol Assess Health Care. 2022. PMID: 35703423

136

"What's Keeping Me Up at Night?" Reflections on the COVID-19 Pandemic in Asia.

Mundy L, Kearney B. Mundy L, et al. Int J Technol Assess Health Care. 2022 Jun 15;38(1):e51. doi: 10.1017/S0266462322000381. Int J Technol Assess Health Care. 2022. PMID: 35702950

137

Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling.

Tarride JE, Gould T, Thomas DM. Tarride JE, et al. Int J Technol Assess Health Care. 2022 Jun 8;38(1):e57. doi: 10.1017/S026646232200040X. Int J Technol Assess Health Care. 2022. PMID: 35674123

138

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.

Oortwijn W, Husereau D, Abelson J, Barasa E, Bayani DD, Santos VC, Culyer A, Facey K, Grainger D, Kieslich K, Ollendorf D, Pichon-Riviere A, Sandman L, Strammiello V, Teerawattananon Y. Oortwijn W, et al. Int J Technol Assess Health Care. 2022 Jun 3;38(1):e37. doi: 10.1017/S0266462322000198. Int J Technol Assess Health Care. 2022. PMID: 35656641 Free PMC article.

139

Values, principles, strategies, and frameworks underlying patient and public involvement in health technology assessment and guideline development: a scoping review.

Pinho-Gomes AC, Stone J, Shaw T, Heath A, Cowl J, Norburn L, Thomas V, Scott S. Pinho-Gomes AC, et al. Int J Technol Assess Health Care. 2022 Jun 3;38(1):e46. doi: 10.1017/S0266462322000289. Int J Technol Assess Health Care. 2022. PMID: 35655444 Review.

140

EUnetHTA's contribution to the new legal framework for health technology assessment cooperation in Europe.

Imaz-Iglesia I, Wild C. Imaz-Iglesia I, et al. Int J Technol Assess Health Care. 2022 Jun 2;38(1):e50. doi: 10.1017/S026646232200037X. Int J Technol Assess Health Care. 2022. PMID: 35652661

141

EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness.

Willemsen A, Ettinger S, Helmink C, Erdos J, Hviding K, Ormstad SS. Willemsen A, et al. Int J Technol Assess Health Care. 2022 May 26;38(1):e41. doi: 10.1017/S0266462322000058. Int J Technol Assess Health Care. 2022. PMID: 35615861

142

Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework - Corrigendum.

Whittal A, Jommi C, De Pouvourville G, Taylor D, Annemans L, Schoonaert L, Vermeersch S, Hutchings A, Patris J. Whittal A, et al. Int J Technol Assess Health Care. 2022 May 24;38(1):e43. doi: 10.1017/S0266462322000290. Int J Technol Assess Health Care. 2022. PMID: 35607832 No abstract available.

143

Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System: the cefiderocol example.

Calleja MÁ, Badia X. Calleja MÁ, et al. Int J Technol Assess Health Care. 2022 May 20;38(1):e48. doi: 10.1017/S0266462322000332. Int J Technol Assess Health Care. 2022. PMID: 35591781 Free article. Review.

144

A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities - Erratum.

Grumberg V, Roze S, Chevalier J, Borrill J, Gaudin AF, Branchoux S. Grumberg V, et al. Int J Technol Assess Health Care. 2022 May 17;38(1):e38. doi: 10.1017/S0266462322000228. Int J Technol Assess Health Care. 2022. PMID: 35577771 Review. No abstract available.

145

Disruptive technologies in health care disenchanted: a systematic review of concepts and examples.

Perleth M, Di Bidino R, Huang LY, Jones L, Mujoomdar M, Myles S, Pichon-Riviere A, Sabirin J, Schuller T, Washington J. Perleth M, et al. Int J Technol Assess Health Care. 2022 May 16;38(1):e70. doi: 10.1017/S0266462322000307. Int J Technol Assess Health Care. 2022. PMID: 35570673

146

Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment-responsible innovation in health approach in the "new normal".

Mukherjee K, Walley T. Mukherjee K, et al. Int J Technol Assess Health Care. 2022 May 13;38(1):e47. doi: 10.1017/S0266462322000319. Int J Technol Assess Health Care. 2022. PMID: 35549786

147

Health Technology Assessment in Support of National Health Insurance in South Africa.

Wilkinson M, Gray AL, Wiseman R, Kredo T, Cohen K, Miot J, Blecher M, Ruff P, Johnson Y, Poluta M, McGee S, Leong TD, Brand M, Suleman F, Maramba E, Blockman M, Jugathpal J, Cleary S, Nematswerani N, Moodliar S, Parrish A, Jamaloodien KK, Stander T, MacQuilkan K, Crisp N, Wilkinson T. Wilkinson M, et al. Int J Technol Assess Health Care. 2022 May 6;38(1):e44. doi: 10.1017/S0266462322000265. Int J Technol Assess Health Care. 2022. PMID: 35513309

148

A model-based study to estimate the health and economic impact of health technology assessment in Thailand.

Kingkaew P, Budtarad N, Khuntha S, Barlow E, Morton A, Isaranuwatchai W, Teerawattananon Y, Painter C. Kingkaew P, et al. Int J Technol Assess Health Care. 2022 May 4;38(1):e45. doi: 10.1017/S0266462322000277. Int J Technol Assess Health Care. 2022. PMID: 35506420 Free article.

149

Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting.

Padmasawitri TIA, Fuady A. Padmasawitri TIA, et al. Int J Technol Assess Health Care. 2022 Apr 28;38(1):e42. doi: 10.1017/S0266462322000241. Int J Technol Assess Health Care. 2022. PMID: 35477587

150

The development process of economic evaluation guidelines in low- and middle-income countries: a systematic review.

Daccache C, Karam R, Rizk R, Evers SMAA, Hiligsmann M. Daccache C, et al. Int J Technol Assess Health Care. 2022 Apr 22;38(1):e35. doi: 10.1017/S0266462322000186. Int J Technol Assess Health Care. 2022. PMID: 35451358

151

Is Value Portable? An Examination of Contextual and Practical Considerations that Affect the Transferability of Value Assessments between Settings.

Synnott PG, Lin PJ, Hickson SS, Glaetzer C, Ollendorf DA. Synnott PG, et al. Int J Technol Assess Health Care. 2022 Apr 21:1-26. doi: 10.1017/S026646232200023X. Online ahead of print. Int J Technol Assess Health Care. 2022. PMID: 35443906 No abstract available.

152

Postlaunch evidence generation practices among health technology assessment bodies in Europe.

Puñal-Riobóo J, Varela-Lema L, Guilhaume C, Galbraith M, Bélorgey C, Faraldo MJ, Meillassoux A. Puñal-Riobóo J, et al. Int J Technol Assess Health Care. 2022 Apr 19;38(1):e33. doi: 10.1017/S0266462322000174. Int J Technol Assess Health Care. 2022. PMID: 35437135

153

European collaboration on health technology assessment: looking backward and forward.

Ruether A, Imaz-Iglesia I, Bélorgey C, Lo Scalzo A, Garrett Z, Guardian M. Ruether A, et al. Int J Technol Assess Health Care. 2022 Apr 19;38(1):e34. doi: 10.1017/S026646232200006X. Int J Technol Assess Health Care. 2022. PMID: 35437132

154

A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment.

Wang Y, Qiu T, Nikodem M, Francois C, Toumi M. Wang Y, et al. Int J Technol Assess Health Care. 2022 Apr 6;38(1):e36. doi: 10.1017/S0266462322000216. Int J Technol Assess Health Care. 2022. PMID: 35382919

155

A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities.

Grumberg V, Roze S, Chevalier J, Borrill J, Gaudin AF, Branchoux S. Grumberg V, et al. Int J Technol Assess Health Care. 2022 Mar 25;38(1):e28. doi: 10.1017/S0266462322000125. Int J Technol Assess Health Care. 2022. PMID: 35331347

156

Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future.

Galbraith M, Guilhaume C, Bélorgey C. Galbraith M, et al. Int J Technol Assess Health Care. 2022 Mar 24;38(1):e30. doi: 10.1017/S0266462322000083. Int J Technol Assess Health Care. 2022. PMID: 35321768

157

The transcatheter aortic valve implantation: an assessment of the generalizability of the economic evidences following a systematic review.

Ruggeri M, Donatella M, Federica C, Salvatore D, Costanza S, Marta C, Paolo R, Marco M. Ruggeri M, et al. Int J Technol Assess Health Care. 2022 Mar 24;38(1):e27. doi: 10.1017/S0266462321001720. Int J Technol Assess Health Care. 2022. PMID: 35321767

158

Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of "Failed" R&D Efforts.

Xie RZ, Towse A, Garrison LP. Xie RZ, et al. Int J Technol Assess Health Care. 2022 Mar 17;38(1):e31. doi: 10.1017/S0266462322000150. Int J Technol Assess Health Care. 2022. PMID: 35297363

159

Acceptability of Manufacturer-Proposed Utility Values for NICE Cancer Medicine Appraisals: Analysis of Manufacturers' Information Sources.

Takada S, Narukawa M. Takada S, et al. Int J Technol Assess Health Care. 2022 Mar 17;38(1):e25. doi: 10.1017/S0266462322000149. Int J Technol Assess Health Care. 2022. PMID: 35297362

160

Key learnings from Institute for Clinical and Economic Review's real-world evidence reassessment pilot.

Jaksa A, Bloudek L, Carlson JJ, Shah K, Chen Y, Patrick AR, McKenna A, Campbell JD. Jaksa A, et al. Int J Technol Assess Health Care. 2022 Mar 14;38(1):e32. doi: 10.1017/S0266462322000162. Int J Technol Assess Health Care. 2022. PMID: 35357284

161

Evidence-Informed Update of Argentina's Health Benefit Package: Application of a Rapid Review Methodology.

Alcaraz A, Alfie V, Gonzalez L, Virgilio S, Garcia-Marti S, Augustovski F, Pichon-Riviere A. Alcaraz A, et al. Int J Technol Assess Health Care. 2022 Mar 11;38(1):e24. doi: 10.1017/S0266462322000034. Int J Technol Assess Health Care. 2022. PMID: 35274604 Review.

162

Facilitating [corrected] More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework.

Whittal A, Jommi C, De Pouvourville G, Taylor D, Annemans L, Schoonaert L, Vermeersch S, Hutchings A, Patris J. Whittal A, et al. Int J Technol Assess Health Care. 2022 Mar 11;38(1):e23. doi: 10.1017/S0266462322000095. Int J Technol Assess Health Care. 2022. PMID: 35274602

163

European Network for Health Technology Assessment's Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics.

Ballini L, Wild C, Djuric O, Mayer-Ferbas J, Willemsen A, Huic M; EUnetHTA COVID-19 Task Force Group. Ballini L, et al. Int J Technol Assess Health Care. 2022 Mar 8;38(1):e22. doi: 10.1017/S0266462322000071. Int J Technol Assess Health Care. 2022. PMID: 35477493

164

Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach.

Krubiner CB, Barsdorf NW, Goldstein SJ, Mosam A, Potgieter S, DiStefano MJ, Tugendhaft A, Merritt MW, Li R, Chalkidou K, Faden RR, Hofman KJ. Krubiner CB, et al. Int J Technol Assess Health Care. 2022 Mar 8;38(1):e26. doi: 10.1017/S0266462322000113. Int J Technol Assess Health Care. 2022. PMID: 35256036

165

A Technical Review of the ISPOR Presentations Database Identified Issues in the Search Interface and Areas for Future Development.

Cooper C, Brown A, Court R, Schauberger U. Cooper C, et al. Int J Technol Assess Health Care. 2022 Mar 8;38(1):e29. doi: 10.1017/S0266462322000137. Int J Technol Assess Health Care. 2022. PMID: 35256029 Review.

166

Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect.

Jankovic D, Payne K, Kanaan M, Bojke L. Jankovic D, et al. Int J Technol Assess Health Care. 2022 Feb 18;38(1):e21. doi: 10.1017/S0266462322000022. Int J Technol Assess Health Care. 2022. PMID: 35177145

167

Synthesizing quantitative and qualitative information on multiple comparisons of health interventions to facilitate knowledge transfer: an example from an EUnetHTA multi-HTA.

Formoso G, Jeroncic A, Bonvicini L, Djuric O, Erdos J, Pezzarossi A, Ballini L. Formoso G, et al. Int J Technol Assess Health Care. 2022 Feb 9;38(1):e20. doi: 10.1017/S0266462322000046. Int J Technol Assess Health Care. 2022. PMID: 35135648

168

Topic selection process in health technology assessment agencies around the world: a systematic review.

Qiu Y, Thokala P, Dixon S, Marchand R, Xiao Y. Qiu Y, et al. Int J Technol Assess Health Care. 2022 Feb 7;38(1):e19. doi: 10.1017/S0266462321001690. Int J Technol Assess Health Care. 2022. PMID: 35129112 Free article.

169

Analysis of consumer comments into PBAC decision-making (2014-9).

Tjeuw E, Wonder MJ. Tjeuw E, et al. Int J Technol Assess Health Care. 2022 Feb 4;38(1):e18. doi: 10.1017/S0266462321001744. Int J Technol Assess Health Care. 2022. PMID: 35115073

170

Addressing uncertainty in relative effectiveness assessments by HTA organizations.

Vreman RA, Strigkos G, Leufkens HGM, Schünemann HJ, Mantel-Teeuwisse AK, Goettsch WG. Vreman RA, et al. Int J Technol Assess Health Care. 2022 Jan 31;38(1):e17. doi: 10.1017/S026646232100177X. Int J Technol Assess Health Care. 2022. PMID: 35094740

171

Understanding innovation of health technology assessment methods: the IHTAM framework.

Jiu L, Hogervorst MA, Vreman RA, Mantel-Teeuwisse AK, Goettsch WG. Jiu L, et al. Int J Technol Assess Health Care. 2022 Jan 31;38(1):e16. doi: 10.1017/S0266462322000010. Int J Technol Assess Health Care. 2022. PMID: 35094736

172

Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3.

Garrett Z, Imaz-Iglesia I, Willemsen A. Garrett Z, et al. Int J Technol Assess Health Care. 2022 Jan 28;38(1):e14. doi: 10.1017/S0266462321001719. Int J Technol Assess Health Care. 2022. PMID: 35086599

173

Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets.

Hofmeister M, Clement F. Hofmeister M, et al. Int J Technol Assess Health Care. 2022 Jan 26;38(1):e15. doi: 10.1017/S0266462321001707. Int J Technol Assess Health Care. 2022. PMID: 35080195

174

Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.

Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu RF, Staniszewska S; CHEERS 2022 ISPOR Good Research Practices Task Force. Husereau D, et al. Int J Technol Assess Health Care. 2022 Jan 11;38(1):e13. doi: 10.1017/S0266462321001732. Int J Technol Assess Health Care. 2022. PMID: 35007499

175

Glycated hemoglobin as a surrogate for evaluating the effectiveness of drugs in diabetes mellitus trials: a systematic review and trial-level meta-analysis.

Rivera PA, Rodríguez-Zúñiga MJM, Caballero-Alvarado J, Fiestas F. Rivera PA, et al. Int J Technol Assess Health Care. 2021 Dec 22;38(1):e12. doi: 10.1017/S0266462321001689. Int J Technol Assess Health Care. 2021. PMID: 34933703

176

Medicine characteristics affecting the time to guidance publication by National Institute for Health and Care Excellence in the single technology appraisal process.

Takada S, Narukawa M. Takada S, et al. Int J Technol Assess Health Care. 2021 Dec 22;38(1):e11. doi: 10.1017/S0266462321001677. Int J Technol Assess Health Care. 2021. PMID: 34933699

177

Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets.

Kalf RRJ, Zuidgeest M, Delnoij DMJ, Bouvy ML, Goettsch WG. Kalf RRJ, et al. Int J Technol Assess Health Care. 2021 Dec 21;38(1):e6. doi: 10.1017/S0266462321000520. Int J Technol Assess Health Care. 2021. PMID: 36317685

178

Exploring facilitators and barriers to introducing health technology assessment: a systematic review.

Suharlim C, Kumar R, Salim J, Mehra M, Gilmartin C, Amaris Caruso A, Castro H. Suharlim C, et al. Int J Technol Assess Health Care. 2021 Dec 21;38(1):e5. doi: 10.1017/S0266462321000623. Int J Technol Assess Health Care. 2021. PMID: 36317684

179

Economic evaluation guidelines in low- and middle-income countries: a systematic review.

Daccache C, Rizk R, Dahham J, Evers SMAA, Hiligsmann M, Karam R. Daccache C, et al. Int J Technol Assess Health Care. 2021 Dec 21;38(1):e1. doi: 10.1017/S0266462321000659. Int J Technol Assess Health Care. 2021. PMID: 34931601

180

Toward a broader concept of societal value: family spillovers in Alzheimer's disease.

Park JY, Marcum ZA, Garrison LP. Park JY, et al. Int J Technol Assess Health Care. 2021 Dec 20;38(1):e7. doi: 10.1017/S0266462321000593. Int J Technol Assess Health Care. 2021. PMID: 36317687 Free PMC article.

181

Opportunities to improve reporting of rapid response in health technology assessment.

de Almeida MO, Montezuma T, de Oliveira Júnior HA, Ferri CP. de Almeida MO, et al. Int J Technol Assess Health Care. 2021 Dec 20;38(1):e4. doi: 10.1017/S0266462321000635. Int J Technol Assess Health Care. 2021. PMID: 36317686

182

Optimizing red blood cell transfusion practices in the intensive care unit: a multi-phased health technology reassessment.

Soril LJJ, Noseworthy TW, Townsend DR, Bagshaw SM, Stelfox HT, Zygun DA, Clement FM. Soril LJJ, et al. Int J Technol Assess Health Care. 2021 Dec 20;38(1):e10. doi: 10.1017/S0266462321001653. Int J Technol Assess Health Care. 2021. PMID: 36317683

183

A framework for action to improve patient and public involvement in health technology assessment.

Silva AS, Facey K, Bryan S, Galato D. Silva AS, et al. Int J Technol Assess Health Care. 2021 Dec 20;38(1):e8. doi: 10.1017/S0266462321000647. Int J Technol Assess Health Care. 2021. PMID: 36317682

184

Mentoring as a potential means to assist consumer representatives contribute effectively to the assessment of health technologies in Australia: a pragmatic review.

Walker C, Donovan J, Watson J. Walker C, et al. Int J Technol Assess Health Care. 2021 Dec 20;38(1):e3. doi: 10.1017/S0266462321000611. Int J Technol Assess Health Care. 2021. PMID: 34924074 Review.

185

A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic.

Agbali R, Balas AE, Beltrame F, De Leo G. Agbali R, et al. Int J Technol Assess Health Care. 2021 Dec 20;38(1):e2. doi: 10.1017/S026646232100060X. Int J Technol Assess Health Care. 2021. PMID: 34924067 Review.

186

Application of a health technology assessment framework to digital health technologies that manage chronic disease: a systematic review.

von Huben A, Howell M, Carrello J, Norris S, Wortley S, Ritchie A, Howard K. von Huben A, et al. Int J Technol Assess Health Care. 2021 Dec 20;38(1):e9. doi: 10.1017/S0266462321001665. Int J Technol Assess Health Care. 2021. PMID: 34924061

187

COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection.

Tomaiuolo R, Derrico P, Ritrovato M, Locatelli M, Milella F, Restelli U, Lago P, Giuliani F, Banfi G. Tomaiuolo R, et al. Int J Technol Assess Health Care. 2021 Sep 22;37(1):e87. doi: 10.1017/S0266462321000441. Int J Technol Assess Health Care. 2021. PMID: 34548114 Free article.

188

A collaborative pilot on current awareness alerts for disinvestment and horizon scanning.

Lauvrak V, Esmail R, Espeland AL, Farrah K, Hafstad E, Harboe I, Migliore A, Ohm IK, Topfer LA. Lauvrak V, et al. Int J Technol Assess Health Care. 2021 Aug 31;37(1):e85. doi: 10.1017/S0266462321000568. Int J Technol Assess Health Care. 2021. PMID: 34462028

189

Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.

Eichler HG, Adams R, Andreassen E, Arlett P, van de Casteele M, Chapman SJ, Goettsch WG, Martinsson JL, Llinares-Garcia J, Nachtnebel A, Pean E, Rasi G, Reksten TR, Timmers L, Vreman RA, van de Vijver I, Wenzl M. Eichler HG, et al. Int J Technol Assess Health Care. 2021 Aug 23;37(1):e83. doi: 10.1017/S026646232100057X. Int J Technol Assess Health Care. 2021. PMID: 34424152

190

[Mecanismos de identificación y priorización de las tecnologías sanitarias a ser evaluadas por las Agencias de ETESA para decisiones de cobertura en Latino America].

Pichon-Riviere A, Augustovski F, Garcia-Marti S, Alcaraz A, Alfie V, Sampietro-Colom L. Pichon-Riviere A, et al. Int J Technol Assess Health Care. 2021 Aug 17;37(1):e81. doi: 10.1017/S0266462321000519. Int J Technol Assess Health Care. 2021. PMID: 34399878 Spanish.

191

Promoting health economic evaluation studies in the AYUSH system of medicine: the need of the hour.

Muthappan S, Bagepally BS, Ponnaiah M. Muthappan S, et al. Int J Technol Assess Health Care. 2021 Aug 16;37(1):e82. doi: 10.1017/S0266462321000386. Int J Technol Assess Health Care. 2021. PMID: 34396945

192

Identification and selection of health technologies for assessment by agencies in support of reimbursement decisions in Latin America.

Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Alfie V, Sampietro-Colom L. Pichon-Riviere A, et al. Int J Technol Assess Health Care. 2021 Aug 16;37(1):e80. doi: 10.1017/S0266462321000416. Int J Technol Assess Health Care. 2021. PMID: 34392842

193

Using INTEGRATE-HTA for the assessment of videorasterstereography in idiopathic scoliosis.

Buchberger B, Wasem J, Spiller L. Buchberger B, et al. Int J Technol Assess Health Care. 2021 Aug 6;37(1):e78. doi: 10.1017/S0266462321000283. Int J Technol Assess Health Care. 2021. PMID: 34353398

194

Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review.

Etangsale A, Nunno L, Pineau J, Prognon P, Martelli N. Etangsale A, et al. Int J Technol Assess Health Care. 2021 Aug 6;37(1):e79. doi: 10.1017/S0266462321000532. Int J Technol Assess Health Care. 2021. PMID: 34353388

195

Health technology assessment applied to emergency preparedness: a new perspective.

Miglietta A, de Waure C, Chronaki C, Wild C, Favaretti C, Timen A, Edelstein M, Petelos E. Miglietta A, et al. Int J Technol Assess Health Care. 2021 Jul 16;37(1):e77. doi: 10.1017/S0266462321000465. Int J Technol Assess Health Care. 2021. PMID: 34269171

196

How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations.

Marsh K, de Bekker-Grob E, Cook N, Collacott H, Danyliv A. Marsh K, et al. Int J Technol Assess Health Care. 2021 Jul 15;37(1):e75. doi: 10.1017/S0266462321000490. Int J Technol Assess Health Care. 2021. PMID: 36744660

197

Considering and communicating uncertainty in health technology assessment.

Trowman R, Powers A, Ollendorf DA. Trowman R, et al. Int J Technol Assess Health Care. 2021 Jul 15;37(1):e74. doi: 10.1017/S0266462321000453. Int J Technol Assess Health Care. 2021. PMID: 34261561 No abstract available.

198

Survey investigating the knowledge and awareness of payers and patient advocacy groups about the health technology assessment process in Lebanon.

Al-Harakeh L, Abbas H, Hassan H, Hallal Z, Hamadeh G, Kurdi M, Abou Selwan C, Karam R. Al-Harakeh L, et al. Int J Technol Assess Health Care. 2021 Jul 1;37(1):e72. doi: 10.1017/S026646232100043X. Int J Technol Assess Health Care. 2021. PMID: 34193326

199

Adherence to country-specific guidelines among economic evaluations undertaken in three high-income and middle-income countries: a systematic review.

Sharma D, Aggarwal AK, Wilkinson T, Isaranuwatchai W, Chauhan AS, Prinja S. Sharma D, et al. Int J Technol Assess Health Care. 2021 Jul 1;37(1):e73. doi: 10.1017/S0266462321000404. Int J Technol Assess Health Care. 2021. PMID: 34193325

200

Systems thinking in health technology assessment: a scoping review.

Richardson M, Ramsay LC, Bielecki JM, Berta W, Sander B. Richardson M, et al. Int J Technol Assess Health Care. 2021 Jun 24;37(1):e71. doi: 10.1017/S0266462321000428. Int J Technol Assess Health Care. 2021. PMID: 34162447 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,824 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,824 results

Results by year